Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
CASE REPORTS

Cerebral Phaeohyphomycosis Caused by Rhinocladiella mackenziei in a Woman Native to Afghanistan

Alejandro Cristini, Dea Garcia-Hermoso, Marie Celard, Gilles Albrand, Olivier Lortholary
Alejandro Cristini
1Department of Neurosurgery C, Hôpital Neurologique Pierre Wertheimer, University of Lyon, Lyon-Montchat, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dea Garcia-Hermoso
2Institut Pasteur, Molecular Mycology Unit and National Reference Center for Mycology and Antifungals
3CNRS URA3012, Paris 75724 Cedex 15
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie Celard
4Department of Microbiology, Center for Biology and Pathology East, Lyon-Bron, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilles Albrand
5Department of Geriatrics, Hôpital Gériatrique Antoine Charial, Lyon-Francheville, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Lortholary
2Institut Pasteur, Molecular Mycology Unit and National Reference Center for Mycology and Antifungals
3CNRS URA3012, Paris 75724 Cedex 15
6University of Paris Descartes, Hôpital Necker-Enfants Malades, Department of Infectious Diseases, Necker Pasteur Infectious Disease Center, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: olortho@pasteur.fr
DOI: 10.1128/JCM.00924-10
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Rhinocladiella mackenziei is a recognized cause of endemic cerebral phaeohyphomycosis in the Middle East area. Surgical resection of the abscesses and posaconazole treatment have improved the ominous prognosis of this disease. We describe the case of a native Afghan woman living in France who presented with brain abscesses due to R. mackenziei.

CASE REPORT

An 80-year-old Afghan woman, native of Kabul, with a history of ischemic heart disease and colon cancer, living in France for 20 years, with no travel to Middle Eastern countries and no return to her native country, was admitted to Antoine Charial Geriatric Hospital (Lyon, France) for a transient episode of aphasia. She was afebrile, alert, and experiencing residual expressive aphasia and had an unremarkable general evaluation. The leukocyte count was 11,400 cells/mm3, 50% of which were lymphocytes. C-reactive protein was at 19.1 mg/dl, and urinary and blood cultures were negative. Noncontrast cerebral computed tomography showed left frontal and temporal cystic lesions associated with a vasogenic edema. The total body scan was normal. Magnetic resonance (MR) imaging disclosed one frontal and one left temporal ring-enhancing lesion, with the largest in the temporal region, measuring 33 by 13 mm (Fig. 1 A). The axial diffusion-weighted MR images show increased signal intensity with a low apparent diffusion coefficient (ADC), indicating abscesses as opposed to solid tumors (Fig. 1B). A keyhole aspiration of the left temporal lesion was carried out, with the evacuation of 12 ml of creamy yellow pus. Direct microscopic examination of the aspiration fluid stained with Gram stain and hematoxylin-eosin stains revealed many leukocytes and several moniliform hyphal structures. Intravenous voriconazole, 200 mg twice daily (BID), was started. The seeding was done in blood agar, chocolate agar PolyViteX, Schaedler agar, and Schaedler broth with 0.02% of vitamin K. Detection of Aspergillus galactomannan and anti-Aspergillus antibodies in serum was negative. After 4 days of incubation at 37°C, black fungi appeared on all seeded cultures that were sent to the National Reference Center for Mycoses and Antifungals (Institut Pasteur, Paris, France). Colonies on 2% malt agar were olive green to brown, with a lanose texture. Microscopic examination revealed short conidiophores arising in right angles from dark-pigmented septate hyphae. At the apex of these conidiophores, unpigmented conidiogenous cells with short, cylindrical denticles produced conidia in sympodial succession (Fig. 2). Conidia were pale brown and ellipsoidal (8 to 10 by 4 to 5 μm), with a prominent basal scar. On the basis of the morphological features described above, the fungus was identified as Rhinocladiella mackenziei (formerly Ramichloridium mackenziei). Genomic DNA was extracted as described previously (18). The universal fungal primer pairs V9D/LS266 (10) and NL1/NL4 (15) were used to amplify the whole ITS1-5.8S-ITS2 region of the ribosomal DNA (rDNA) and the D1/D2 region of the large-subunit rDNA, respectively (9, 14, 18). PCR products were then sequenced at the sequencing facility of the Institut Pasteur. The nucleotide sequence analysis of the internal transcribed spacer (ITS) and the 28S region showed 96% and 99.2% identity, respectively, with the R. mackenziei type strain isolate CBS 650.93 (GenBank accession number AF050288). Unfortunately, at the time of writing, the culture stored at −80°C was no longer viable and prevented antifungal susceptibility testing. Two weeks after surgery, voriconazole treatment was stopped and oral posaconazole (400 mg BID) was initiated, based on a previous case report (3). Four months after surgery, the patient was conscious, with a stable neurological status. Brain computed tomography disclosed the disappearance of the right temporal lesion, seen in the previous brain computed tomography control, and a decrease of the size of the left frontal and temporal lesions. She was discharged, and treatment by posaconazole (400 mg BID) was maintained. The patient died 7 months postoperatively due to intercurrent inhalation pneumonia while still receiving posaconazole.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

(A) Postcontrast axial T1-weighted MR image showing the rim-enhancing left temporal lesion with a central hypointensity. (B) The low ADC suggests the diagnosis of abscesses.

FIG. 2.
  • Open in new tab
  • Download powerpoint
FIG. 2.

(A and B) Conidial apparatus of R. mackenziei. (C) Sympodially proliferating conidiogenous cells and conidia.

Dematiaceous fungi represent a large and heterogeneous group of filamentous molds containing melanin in their cell walls. The term phaeohyphomycosis was proposed by Ajello and Georg in 1974 as “a collective name for a group of mycosis caused by diverse genera and species of dematiaceous fungi” (1). In 2007, Arzanlou et al. integrated DNA sequence data into morphological and cultural features to resolve the species concepts and generic limits of the taxa currently placed in Periconiella, Ramichloridium, Rhinocladiella, and Veronaea and found that Rhinocladiella mackenziei was the synonym of Ramichloridium mackenziei and proposed the former name (5). R. mackenziei is a neurotropic fungus limited to patients living or coming from Middle Eastern countries, mostly from Saudi Arabia and Kuwait (Table 1). This fungus has not yet been isolated from nature, and its predilection for people living in the Middle East suggests a preference for the saprophytic phase, if existent, within arid climates (11). Of note, Ur-Rahman et al. suggested the inhalation of the fungus as a presumable portal of entry after a report of a patient with small miliary lesions in the lungs (21). Hematogenous dissemination could explain the brain infection. Based on the present description, it may be hypothesized that the latency may persist for years, as our patient had not returned to Afghanistan for 20 years. To the best of our knowledge, 21 other cases have been reported between 1983 and 2010 (3, 4, 5, 8, 9, 13, 14, 17, 19, 21). The fungus affects adults with a median age of 62 years (range, 32 to 80 years), without male predominance. An underlying disease or immunosuppression has been noticed in 14 of the previously reported cases, while 5 did not present any particular underlying disease (8, 21). Information is lacking for the 2 remaining cases (Table 1). Brain abscess is the classic pathological form at clinical presentation. Single lesions were present in 70% of cases (3, 5, 6, 8, 12, 13, 14, 19, 21). Similar to pyogenic abscess, fungal abscesses, including those caused by R. mackenziei, show a hyperintensity in diffusion-weighted imaging sequences and hypointensity in ADC maps (9). The majority of patients were treated with a combination of medical and surgical treatments. Most commonly used antifungals were amphotericin B, flucytosine, usually associated with amphotericin B, and itraconazole. This classically medical treatment was associated with a mortality of 100% (4, 6, 8, 12, 13, 14, 17, 19, 20, 21). Al-Abdely et al. compared in vitro activities and experimental efficacies of posaconazole, amphotericin B, and itraconazole against R. mackenziei and found posaconazole to be superior in reducing the brain fungal burden (2). Posaconazole (16) was previously given in two cases, and Al-Abdely et al. reported the only case of prolonged survival (4 years) in combination with surgery (3). Badali et al. showed that posaconazole has the best in vitro activity; however, because no in vitro formula is available, isavuconazole might be second best (7). Surgical resection of the abscess was used in 33% of the cases, while 67% were treated by aspiration. Ur-Rahman et al. reported the presence of branching fungal hyphae in the peripheral zone of gliosis surrounding the abscess after histological evaluation of one operative case (21). Surgical aspiration provides a transient relief of the mass effect, but surgical resection seems to be a suitable treatment for eradicating the fungus. Although rarely described, cerebral phaeohyphomycosis by R. mackenziei should be suspected in people with an isolated cystic brain lesion living in or coming from the Middle East, even multiple years after having left the area where cerebral phaeohyphomycosis is endemic. In 2010, Badali et al. reported the first case of cerebral abscess by Rhinocladiella mackenziei in India, which should now be added to the list of areas where cerebral phaeohyphomycosis is endemic, like Afghanistan, based on the present observation (6). Knowing that United States and European troops are still based in Afghanistan, one should be aware of more imported cases in returning soldiers. Surgical resection of the abscesses when they are solitary, superficial, not in motor cerebral areas, and not beside the ventricle system seems to be the more suitable surgical option. Posaconazole therapy should be promptly initiated and maintained for months.

View this table:
  • View inline
  • View popup
TABLE 1.

Summary of clinical data of cerebral case reports of Rhinocladiella mackenziei

Nucleotide sequence accession numbers.Nucleotide sequences were deposited in GenBank under accession numbers HM359013 (ITS) and HM359014 (D1/D2).

ACKNOWLEDGMENTS

We gratefully acknowledge the technical help of Laure Diancourt and Coralie Tran at the sequencing facility (PF-8 Genotyping of Pathogens and Public Health, Institut Pasteur).

FOOTNOTES

    • Received 8 May 2010.
    • Returned for modification 21 May 2010.
    • Accepted 21 June 2010.
  • Copyright © 2010 American Society for Microbiology

REFERENCES

  1. 1.↵
    Ajello, L., and L. K. Georg. 1974. A case of phaeohyphomycosis caused by a new species of Phialophora. Mycologia 66 : 490-498.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    Al-Abdely, H. M., L. Najvar, R. Bocanegra, A. Fothergill, D. Loebenberg, M. G. Rinaldi, and J. R. Graybill. 2000. SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum (“Ramichloridium mackenziei”). Antimicrob. Agents Chemother. 44 : 1159-1162.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Al-Abdely, H. M., A. M. Alkhunaizi, J. A. Al-Tawfiq, M. Hassounah, M. G. Rinaldi, and D. A. Sutton. 2005. Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole. Med. Mycol. 43 : 91-95.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Amr, S. S., and J. A. Al-Tawfiq. 2007. Aspiration cytology of brain abscess from a fatal case of cerebral phaeohyphomycosis due to Ramichloridium mackenziei. Diagn. Cytopathol. 35 : 695-699.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Arzanlou, M., J. Z. Groenewald, W. Gams, U. Braun, H.-D. Shin, and P. W. Crous. 2007. Phylogenetic and morphotaxonomic revision of Ramichloridium and allied genera. Stud. Mycol. 58 : 57-93.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Badali, H., J. Chander, S. Bansal, A. Aher, S. S. Borkar, J. F. Meis, and G. S. De Hoog. 2010. First autochthonous case of Rhinocladiella mackenziei cerebral abscess outside the Middle East. J. Clin. Microbiol. 48 : 646-649.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    Badali, H., G. S. de Hoog, I. Curfs-Breuker, and J. F. Meis. 2010. In vitro activities of antifungal drugs against Rhinocladiella mackenziei, an agent of fatal brain infection. J. Antimicrob. Chemother. 65 : 175-177.
    OpenUrlCrossRefPubMed
  8. 8.↵
    Campbell, C. K., and S. S. A. Al-Hedaithy. 1993. Phaeohyphomycosis of the brain caused by Ramichloridium mackenziei sp. nov. in Middle East countries. J. Med. Vet. Mycol. 31 : 325-332.
    OpenUrlCrossRef
  9. 9.↵
    Gaviani, P., R. B. Schwartz, E. T. Hedley-Whyte, K. L. Ligon, A. Robicsek, P. Schaefer, and J. W. Henson. 2005. Diffusion-weighted imaging of fungal cerebral infection. Am. J. Neuroradiol. 26 : 1115-1121.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Gerrits van den Ende, A. H. G., and G. S. de Hoog. 1999. Variability and molecular diagnostics of the neurotropic species Cladophialophora bantiana. Stud. Mycol. 43 : 151-162.
    OpenUrl
  11. 11.↵
    Horré, R., and G. S. de Hoog. 1999. Primary cerebral infections by melanized fungi: a review. Stud. Mycol. 43 : 176-193.
    OpenUrl
  12. 12.↵
    Kanj, S. S., S. S. Amr, and G. D. Roberts. 2001. Ramichloridium mackenziei brain abscess: report of two cases and review of the literature. Med. Mycol. 39 : 97-102.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Kashgari, T. Q., H. Al-Miniawi, and M. K. Moawad Hanna. 2000. Cerebral phaeohyphomycosis caused by Ramichloridium mackenziei in the Eastern province of Saudi Arabia. Ann. Saudi Med. 20 : 457-460.
    OpenUrlPubMedWeb of Science
  14. 14.↵
    Khan, Z. U., S. J. Lamdhade, M. Johny, J. Al-Khalidi, A. Thussu, H. N. Yossef, I. Al-Obaid, and A. A. Nasser. 2002. Additional case of Ramichloridium mackenziei cerebral phaeohyphomycosis from the Middle East. Med. Mycol. 40 : 429-433.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    Kurtzman, C. P., and C. J. Robnett. 1997. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5′ end of the large-subunit (26S) ribosomal DNA gene. J. Clin. Microbiol. 35 : 1216-1223.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    Morris, I. M. 2009. Posaconazole: a new antifungal agent with an expanded spectrum of activity. Am. J. Health Syst. Pharm. 66 : 225-236.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    Podnos, Y. D., P. Anastasio, L. De La Maza, and R. Kim. 1999. Cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (Ramichloridium mackenziei): case report. Neurosurgery 45 : 372-375.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    Schwarz, P., S. Bretagne, J. C. Gantier, D. Garcia-Hermoso, O. Lortholary, F. Dromer, and E. Dannaoui. 2006. Molecular identification of zygomycetes from culture and experimentally infected tissues. J. Clin. Microbiol. 44 : 340-349.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    Sutton, D. A., M. Slifkin, R. Yakulis, and M. G. Rinaldi. 1998. U.S. case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. mackenziei): criteria for identification, therapy, and review of other known dematiaceous neurotropic taxa. J. Clin. Microbiol. 36 : 97-102.
    OpenUrl
  20. 20.↵
    Taj-Aldeen, S. J., M. Almaslamani, A. Alkhal, I. Al Bozom, A. M. Romanelli, B. L. Wickes, A. W. Fothergill, and D. Sutton. 2010. Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei (formerly Ramichloridium mackenziei): a taxonomic update and review of the literature. Med. Mycol. 48 : 546-556.
    OpenUrlCrossRefPubMed
  21. 21.↵
    Ur-Rahman, N., E. S. Mahgoub, and A. H. Chagla. 1988. Fatal brain abscesses caused by Ramichloridium obovoideum: report of three cases. Acta Neurochir. (Wien) 93 : 92-95.
    OpenUrlCrossRefPubMedWeb of Science
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Cerebral Phaeohyphomycosis Caused by Rhinocladiella mackenziei in a Woman Native to Afghanistan
Alejandro Cristini, Dea Garcia-Hermoso, Marie Celard, Gilles Albrand, Olivier Lortholary
Journal of Clinical Microbiology Aug 2010, 48 (9) 3451-3454; DOI: 10.1128/JCM.00924-10

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Cerebral Phaeohyphomycosis Caused by Rhinocladiella mackenziei in a Woman Native to Afghanistan
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Cerebral Phaeohyphomycosis Caused by Rhinocladiella mackenziei in a Woman Native to Afghanistan
Alejandro Cristini, Dea Garcia-Hermoso, Marie Celard, Gilles Albrand, Olivier Lortholary
Journal of Clinical Microbiology Aug 2010, 48 (9) 3451-3454; DOI: 10.1128/JCM.00924-10
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • CASE REPORT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Ascomycota
brain abscess
Central Nervous System Fungal Infections

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X